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Summary expressivity (Hopsu-Havu and Peltonen 1970; Nir and
Tanzer 1978; Maldonado-Ruiz et al. 1982; Nazzaro and
The erythrokeratodermas (EKs) are a group of disorders
Blanchet-Bardon 1986; Lamprecht et al. 1988; Kudsi
characterized by erythematous plaques associated with
and Naeyaert 1990; MacFarlane et al. 1991; Miura etvariable features that include palmoplantar kerato-
al. 1991; Kiesewetter et al. 1993; Niemi and Kanervaderma. One type of EK is known as ‘‘progressive sym-
1993; Gray et al. 1996). Only Ç30 cases have appearedmetric erythrokeratoderma’’ (PSEK). We studied mem-
in the literature since the initial description, by Darierbers of a family of Japanese origin in which the index
in 1911, entitled ‘‘Erythrokeratodermie Verruqueuse encase with PSEK had had well-demarcated nonmigratory
Nappes, Symetrique et Progressive’’ (Darier 1911). Non-erythematous plaques on her extremities since birth. Se-
migratory erythematous plaques develop shortly afterquence determination of the loricrin gene revealed an
birth and are distributed symmetrically over the body,insertion of a C following nucleotide 709. The mutation
particularly on the extremities (hands and feet), the but-results in a frameshift that changes the terminal 91
tocks, and sometimes the face, together with pal-amino acids in the wild-type polypeptide into missense
moplantar keratoderma.amino acids and adds 65 additional residues. This fur-
EK variabilis (EKV), a second major clinical subtypether implicates loricrin defects in the pathogenesis of
of EK, was ﬁrst described by Mendes da Costa in 1925,disorders with palmoplantar keratoderma and pseu-
as relatively ﬁxed patches of hyperkeratosis with ery-doainhum.
thematous areas ‘‘characterized by capriciously formed
outlines, like the boundary lines of seacoasts on maps’’
Introduction (Mendes da Costa 1925). EKV is also inherited in an
autosomal dominant pattern, with variable expressivity,A clinically and genetically heterogeneous group of dis-
and the erythematous areas move from hour to hour.orders known as the ‘‘erythrokeratodermas’’ (EKs) is
The condition is usually evident at birth or within thecharacterized by widespread erythematous plaques, ei-
1st year of life; lesions predominantly affect the face,ther stationary or migratory, associated with features
buttocks, and extremities; and palmoplantar kerato-that include palmoplantar keratoderma (Nir and Tanzer
derma is generally present. The major factor distinguish-1978; Gray et al. 1996; Stevens et al. 1996; Christiano
ing between PSEK and EKV is the sharply outlined geo-1997). The genetic defects underlying the EKs are still
graphical regions of migratory erythema in the latterlargely unknown (Stevens et al. 1996; Christiano 1997).
(Mendes da Costa 1925; Brown and Kierland 1966;One type of EK, known as ‘‘progressive symmetric
Hopsu-Havu and Tuohimata 1971).erythrokeratoderma’’ (PSEK), which is characterized by
Are the EKs one disorder? Macfarlane and colleagueserythematous and hyperkeratotic plaques inherited in
posed this question in 1991, when they reported clinicalan autosomal dominant fashion, has been noted by some
and ultrastructural studies of two sisters, in which theauthors to display incomplete penetrance and variable
younger sister appeared to have EKV whereas the older
sister’s presentation was more consistent with PSEK
(MacFarlane et al. 1991). They speculated that theseReceived April 18, 1997; accepted for publication June 17, 1997.
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Department of Dermatology, Columbia University, College of Physi- and underscored the difﬁculty in distinguishing the het-
cians and Surgeons, 630 West 168th Street, VC-1526, New York, NY erogeneous EK phenotypes on the basis of clinical pre-
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0002-9297/97/6103-0016$02.00 reﬁned to a locus on chromosome 1p32-34 (van der
581
582 Am. J. Hum. Genet. 61:581–589, 1997
Schroeff et al. 1984, 1988; Richard et al. 1996), in a Clinical Samples
region of candidate connexin genes involved in epider- DNA was isolated from peripheral blood leukocytes
mal differentiation. In contrast to the linkage of EKV of the proband and both parents, according to standard
to chromosome 1p, no locus for PSEK had previously techniques (Sambrook et al. 1979). Skin biopsies were
been deﬁned by genetic linkage studies. obtained from involved areas of the thighs (cases 1 and
In this study, we report identiﬁcation of a frameshift 2) and the knee (case 1), under local anesthesia and after
mutation in the loricrin gene on chromosome 1q21 in informed consent had been obtained. Normal human
a family with PSEK. Loricrin is the major structural skin samples from the thigh, which were obtained during
component of the corniﬁed cell envelope, formed be- plastic surgery, were used for comparison.
neath the plasma membrane of stratiﬁed squamous epi-
thelial cells during terminal differentiation (Hohl et al. Mutation Identiﬁcation and Characterization
1991; Yoneda et al. 1992). These data establish that this The sequence of exon 2 of the loricrin gene was PCR
clinical variant of PSEK is genetically distinct from the ampliﬁed from genomic DNA by use of the ExpandTM
forms of EKV linked to chromosome 1p, and they fur- Long Template PCR System kit with High Fidelity Taq
ther implicate components of the corniﬁed cell envelope (Boehringer Mannheim). The loricrin gene is encoded
in the pathogenesis of disorders typiﬁed by pal- by two exons, with the entire coding sequence contained
moplantar keratoderma and pseudoainhum (Maestrini within the second exon. The primers, designed from the
et al. 1996). published sequence (GenBankM94077) (Maestrini et al.
1996), were 5-GCTGAGGCTCTGGCACCTGAAAG-Subjects, Material, and Methods
3 (forward) and 5- GCCGGAGAGCTCAATGGC-Clinical Description
TTCT-3 (reverse) and produce a PCR product of 1,235
The proband (III-1; ﬁg. 1) was a 27-year-old female bp. PCR conditions were 1 min at 95C, 45 s at 65C,
of Japanese origin who was the only child of nonconsan- and 2 min at 72C, for 35 cycles. PCR products were
guineous parents. Her father (II-3), two paternal uncles puriﬁed on Centriﬂex gel-ﬁltration cartridges (Advanced
(II-6 and II-7), and her paternal grandfather (I-3) were Genetic Technologies) and were directly sequenced by
similarly affected with EK. She presented with erythema- use of the ABI PRISMTM Dye Terminator Cycle Sequenc-
tous skin lesions on the trunk, face, and extremities and ing Kit with AmpliTaq DNA Polymerase FS (Perkin
with palmoplantar keratotic lesions (ﬁg. 2A and C). Elmer–ABI). The sequences were run on an ABI 310
Some clinical and histological features of this case have Prism Sequencer (Applied Biosystems).
been published previously in the Japanese literature Allele-speciﬁc oligonucleotides (ASOs) were prepared
(Ishida et al. 1986, 1987). Her lesions developed soon for speciﬁc hybridization to both the wild-type and
after birth and did not change much thereafter. She had mutant sequences: wild-type, ASO 5-TGCGCGCCC-
no migratory erythematous lesions, nor did she have CAGCCGAG-3; mutant, ASO 5-TGCGCGCCCCCA-
any blistering. Her hearing was normal, and audiometry GCCGA-3. After end labeling of each oligomer, ﬁlters
showed a normal pattern. were hybridized in 5 1 SSPE, 0.5% SDS at 37C for 30
There were well-demarcated red-colored ﬁgurate min and were washed at the annealing temperature of
plaques with white pityriasiform scales on the extensor the ASOs (62C) (in 2 1 SSPE, 0.1% SDS) and subse-
and ﬂexor surfaces of the extremities, abdomen, and quently with increasing stringency. Signals were ob-
buttocks (ﬁg. 2C). Her face showed diffuse erythema. tained after exposure to x-ray ﬁlm and autoradiography.
Her palms and soles were hyperkeratotic and had a
waxy appearance (ﬁg. 2A). Her palms had a honeycomb
Protein and Secondary-Structure Predictionspattern as well. Her hair, teeth, and nails appeared nor-
Computer-assisted analysis of the mutant polypeptidemal, and she had a very small right third toe. Pseudoain-
was performed by use of protein-manipulation softwarehum, constricting bands encircling the interphalangeal
from Genetics Computing Group (1994).joints of the digits of the hands and feet, was noted on
the distal interphalangeal joints of both 5th ﬁngers, and
Light and Electron Microscopymild constrictions were noted on the joints of other ﬁn-
gers (ﬁg. 2A). Light-microscopic examination was performed either
on semithin sections of Epon-embedded samples pro-II-3, the 57-year-old father of the proband, had simi-
lar symptoms (ﬁg. 2B and D). He had well-demarcated cessed for electron microscopy and stained with tolu-
idine blue or on material that was ﬁxed in formalin,widespread erythematous plaques on his extremities.
His palms and soles were hyperkeratotic, and the 5th embedded in parafﬁn, sectioned, and stained with hema-
toxylin and eosin. For transmission-electron micros-ﬁngers of both hands showed mild constrictions on the
distal interphalangeal joints. His hair, teeth, nails, and copy, the skin samples were processed as described else-
where (Ishida-Yamamoto and Iizuka 1995). Ultrathinhearing were all normal.
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Figure 1 Pedigree and mutation analysis in proband and nuclear famiy. A, Three known generations of Japanese family affected with
EK. The proband is represented by the blackened circle (individual III-1) (arrow). Her father (II-3), two paternal uncles (II-6 and II-7), and
paternal grandfather (I-3) were similarly affected and are represented by blackened squares. A diagonal line through a symbol indicates that
the individual is deceased. B, Direct automated sequence analysis of loricrin gene, indicating single-base-pair insertion of a C nucleotide after
position 709, indicated, by the arrow in the proband’s sequence (lower panel), as 709insC, compared with the control sequence (upper panel).
C, Mutation conﬁrmed in proband (lanes P) and affected father (lanes P), by ASO hybridization. The wild-type ASO hybridizes with PCR-
ampliﬁed genomic DNA from the proband, father, mother (lanes M), and an unrelated, unaffected control individual (C) (upper panel), whereas
the mutant ASO hybridizes only to the PCR-ampliﬁed genomic DNA of the proband and her father (lanes P and lanes F, respectively) (lower
panel).
sections were cut and were stained with uranyl acetate International). The involucrin antibody (SY5) is a mouse
monoclonal antibody (Hudson et al. 1992), and 15 nmand lead citrate.
of gold-conjugated goat anti-mouse antibody was the
Immunoelectron Microscopy secondary antibody (Amersham), whereas 5 nm of gold-
Postembedding immunoelectron microscopy was per- conjugated goat anti-rabbit antibody (Amersham) was
formed as described elsewhere (Ishida-Yamamoto et al. used for the loricrin antibody AF2340.
1996). In brief, the skin samples were frozen without
chemical ﬁxation, were subjected to freeze substitution Results
in methanol, and were embedded in Lowicryl K11M
(Chemische Werke Lowi). The immunostaining proce- Direct automated sequencing of the loricrin gene was
performed because the clinical and histological ﬁndingsdures were as described elsewhere (Ishida-Yamamoto
et al. 1996). For loricrin staining, a rabbit polyclonal (see below) suggested that this gene was a potential can-
didate. There was a single-base-pair insertion of a Cantibody (AF2340) raised against a mouse loricrin N-
terminal peptide (Ishida-Yamamoto et al. 1996) was following nucleotide 709 of the loricrin DNA sequence
(numbering is according to GenBank M61120) (Hohl etused, and the secondary antibody was 10 or 15 nm of
gold-conjugated goat anti-rabbit antibody (Amersham al. 1991) (ﬁg. 1B). The mutation, designated ‘‘709insC,’’
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Figure 2 Characteristic clinical and histological features of PSEK. A, Hyperkeratotic and honeycomb-like waxy appearance of palm (case
1). Marked pseudoainhum is noted on the joint of the 5th ﬁnger (arrowheads), and mild constrictions on the joints of other ﬁngers are also
seen. B, Diffuse erythema, marked furrows, and small lamellar scales on feet (case 2). Nails appear normal. C and D, Well-demarcated red-
colored ﬁgurative plaques with white pityriasiform lamellar scales on buttocks (case 1) and thigh (posterior aspect; case 2). E and F, Hematoxylin
and eosin-stain section from knee lesion (case 1). Note marked hyperkeratosis with parakeratosis, hypergranulosis, and moderate acanthosis.
Retained nuclei in the corniﬁed cells are indicated by arrowheads in F. Bar Å 0.1 mm in E and 10 mm in F.
resulted in a frameshift and a delayed termination codon proximately one-third of the glutamine and lysine resi-
dues involved in isodipeptide cross-link formation.in the loricrin mRNA. The mutation was conﬁrmed in
the father and the proband by use of ASO hybridization All biopsy skin samples from involved areas of the
thighs and the knee showed similar histological features.(ﬁg. 1C). The frameshift caused the replacement of the
C-terminal 91 amino acids and extended the chain by Light microscopy showed marked hyperkeratosis with
parakeratosis, a thickened granular cell layer, mild acan-an additional 65 residues. The entire wild-type loricrin
polypeptide is 315 amino acids in length, so this muta- thosis, and mild lymphocytic inﬁltration around the su-
perﬁcial blood vessels (ﬁg. 2E and F). The most strikingtion effectively replaced the carboxy-terminal one-third
of loricrin with missense amino acids and removed ap- abnormality was the presence of intranuclear granules
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Figure 3 Electron microscopy showing abnormal epidermal differentiation in patient skin. A, Superﬁcial granular cell containing many
characteristic intranuclear granules (arrowheads). Note the presence of a transitional cell layer (T) and increased intercellular substance derived
from lamellar granules (*). k Å keratohyalin granules; l Å lipid droplets; and n Å nucleolus. Bar Å 1 mm. B, Corniﬁed-cell envelopes (arrows)
in patient skin, which is thinner than in normal skin (inset). d Å desmosomes. Bars Å 0.1 mm. Biopsy samples are from the thigh of case 2 (A
and B) and from a healthy individual (inset in B).
in the upper granular cells (ﬁg. 3A). Although the granu- Discussion
lar-cell layers were thickened, keratohyalin granules ap-
In this study, we report the molecular basis of PSEKpeared normal (ﬁg. 3A). The transitional cell layer,
in this family as a delayed termination mutation in thewhich is only occasionally observed in normal skin, was
loricrin gene. Furthermore, we have analyzed the impacta prominent feature between the granular and corniﬁed
of this mutation on corniﬁed cell envelope formation atcells (ﬁg. 3A). Lamellar granules were increased in num-
the ultrastructural level, as well as its effect on cross-ber in the spinous and granular cells, and the intercellu-
linking and rigidiﬁcation of the protein (see below). Al-lar substance derived from these granules was abundant
though clinically it appeared that this patient had un-in both (ﬁg. 3A). Lipid droplets and remnants of cellular
equivocal diagnostic features of PSEK, we initiated mo-organelles were present in the corniﬁed cells (ﬁg. 3A).
lecular analysis of the loricrin gene on the basis of moreThin, electron-dense cell envelopes were seen in the su-
subtle clinical and histological similarities with a formperﬁcial granular cells. However, the increase in thick-
of palmoplantar keratoderma known as ‘‘Vohwinkelness of cell envelopes in the horny layer that occurs
syndrome’’ (Vohwinkel 1929; Camisa and Rossanain normal skin was not observed in the patient’s skin
1984; Camisa et al. 1988), in which we elsewhere had(ﬁg. 3B).
identiﬁed a different loricrin mutation (Maestrini et al.To identify the composition of the granules, immuno-
1996). These similarities included palmoplantar hyper-electron microscopy was used to show that intranuclear
keratosis with a honeycomb appearance, pseudoain-granules in the granular cells were loricrin immunoreac-
hum, and ichthyotic lesions on other body sites, al-tive (ﬁg. 4A). The retained nuclei in the parakeratotic
though the PSEK cases had signiﬁcantly morecorniﬁed cells also contained loricrin-positive granules
widespread and striking erythematous hyperkeratotic(ﬁg. 5A and C). However, corniﬁed cell envelopes were
plaques.sparsely labeled with the loricrin antibody (ﬁg. 5B and
The nature of the EK mutation in the loricrin gene isC), which is in complete contrast to the labeling pattern
also reminiscent of the VS mutation (Maestrini et al.in normal skin, where loricrin antibodies intensely deco-
1996), in terms of both its location within the gene andrate corniﬁed cell envelopes (ﬁg. 5D). The most superﬁ-
its functional consequences. The EK mutation is a 1-cial granular cells or transitional cells of the patient’s
bp insertion of a C (709insC) after a stretch of fourskin often showed more loricrin labels on the cell enve-
consecutive C nucleotides, residing only 21 bp upstreamlopes than in the matured corniﬁed cells (ﬁg. 5B). This
of the VS mutation, which is a 1-bp insertion of a Gpattern has not been observed in normal skin and is in
(730insG) after a stretch of six consecutive G nucleotideskeeping with aberrant corniﬁed cell envelope assembly.
(Maestrini et al. 1996) (ﬁg. 6). The EK mutation resultsInvolucrin labels on the corniﬁed cell envelopes in the
in a frameshift and delayed termination of transcription,patient’s skin were greater than those in normal skin
(ﬁg. 5B–D). with replacement of the 91 carboxy-terminal amino
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Figure 4 Immunoelectron microscopy showing abnormal loricrin staining in patient skin: loricrin labeling in granular cells. Immunoreac-
tion is heavily accumulated on the intranuclear aggregates (arrowheads) in the patient skin. Normal skin shows diffuse cytoplasmic and
nucleoplasmic labels not associated with granules. Biopsy samples are from the thigh of case 2 (A) and from a healthy individual (B).
N Å nuclei. Bars Å 1 mm.
acids by 91 missense amino acids (ﬁg. 6). Furthermore, and Fasman 1978; Rost and Sander 1993; Rost 1995;
Rost et al. 1995, 1996). This result is consistent withthe mutant transcript overrides the endogenous termina-
tion and recognizes a novel termination codon 65 nucle- the observation, on the basis of circular dichroism, that
native loricrin has no secondary structure (Candi et al.otides downstream, thereby extending the loricrin poly-
peptide an additional 22 amino acids (ﬁg. 6). This novel 1995). Therefore, we expect that the primary determi-
nant of loricrin structure is cross-linking (Steinert andC-terminus is remarkably similar to the VS mutation,
which creates the identical 84 missense amino acids, in Marekov 1994). The protein-analysis methods also pre-
dict that there will be no signiﬁcant secondary structureaddition to the 22-amino-acid extension (Maestrini et
al. 1996). generated in the mutated C-terminal region. Thus, when
the native cross-linking is disrupted by the mutation, theWe predict that the mechanism of action of this muta-
tion on the disruption of the envelope acts in two ways: mutated region becomes a random coil, causing both
increased rigidiﬁcation and loss of ﬂexibility of the pro-(1) by impairing and disrupting its ability to cross-link
to itself and to other corniﬁed cell envelope components tein, as well as the potential for dominant-negative inter-
actions with other loricrin molecules and/or other enve-and (2) by diminishing its ﬂexibility, perhaps rendering
it more rigidly structured. First, 17 of 23 unique intra- lope components.
We speculate that some normal loricrin molecules aremolecular crosslinks formed by transglutaminases I and
III in vitro (Candi et al. 1995) are broken by the muta- participating in corniﬁed cell envelope formation, since
we do not observe erythematous lesions over the entiretion. Second, the relative number of intermolecular
cross-links between loricrin and other corniﬁed cell en- body surface and since areas of uninvolved skin were
clearly evident in these two cases with PSEK. It may bevelope proteins that are disrupted by the mutation
(Steinert and Marekov 1994, 1997) are known. It is possible that there is some redundancy in the structure
of the envelope or that other corniﬁed-cell-envelope pre-clear that, although the mutation disrupts most of the
loricrin-loricrin intermolecular cross-links, the majority cursors may be compensating for the abnormalities in
loricrin. This hypothesis is supported by the observationof the cross-links between loricrin and other proteins are
left intact, with the exception of the loricrin-involucrin of only a minimal erythematous phenotype lasting only
4–5 d in a mouse model in which the loricrin gene hadassociation, in which half the cross-links are broken.
Secondary structure–prediction methods give further been inactivated by targeted ablation (de Viragh et al.
1997). In the skin of the loricrin-deﬁcient mice, evidenceinsights into the structural changes at the C-terminus
that are incurred as a result of the mutation. Very little for compensation by SPR-2 and involucrin was evident
in neonates and in 4-d-old mice, respectively, but failedof the native loricrin protein is either alpha-helix or beta
sheet in its structure, and it is predicted that this protein to correct a defect in barrier function (de Viragh et al.
1997). Although we have not performed any quantita-has no alpha or beta secondary structure at all (Chou
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Figure 5 Loricrin (labeled with 5 nm gold) and involucrin (labeled with 15 nm gold) double staining demonstrating aberrant corniﬁed-
cell-envelope formation. The areas marked by boxed numerals ’’1‘‘ and ’’2‘‘ in A are shown at a higher magniﬁcation in B and C, respectively.
Note both the temporal cell peripheral accumulation of loricrin labels (arrows in B) in the most superﬁcial granular cells and disappearance
of the labels on the cell envelopes of corniﬁed cells in patient skin. Compare that with rich loricrin labeling in normal corniﬁed-cell envelopes
(D). Granular aggregates (*) within the parakeratotic corniﬁed-cell nucleus are densely labeled with the loricrin antibody (C). Involucrin labels
(arrowheads) on the corniﬁed-cell envelopes are rich in patient skin (B and C) but not in normal skin (D). G Å granular cells; and C Å corniﬁed
cells. Biopsy samples are from the thigh of case 2 (A–C) and a healthy individual (D). N Å nuclei. Bar Å 5 mm in A and 0.1 mm in B–D.
tive analysis of involucrin expression in the PSEK family, Bardon 1986; Lamprecht et al. 1988; Kudsi and Naey-
aert 1990; MacFarlane et al. 1991; Miura et al. 1991;a similar compensatory mechanism may contribute to
the apparent increase of involucrin deposition by immu- Kiesewetter et al. 1993; Niemi and Kanerva 1993; Gray
et al. 1996). Furthermore, there are several reports innoelectron microscopy, together with an unmasking of
involucrin epitopes in the absence of loricrin (ﬁg. 5B the literature that describe ultrastructural ﬁndings in EK;
yet, as far as we are aware, none of them has shownandC). Both the explanation of the dramatic phenotypic
expression in a palmoplantar distribution despite ubiq- ﬁndings similar to those in the cases presented in the
present study (Nazzaro and Blanchet-Bardon 1986;uitous expression of the loricrin gene and the pathogene-
sis of the pseudoainhum are matters that remain to be Lamprecht et al. 1988; Kudsi and Naeyaert 1990; Mac-
Farlane et al. 1991; Miura et al. 1991; Kiesewetter etexplored.
The clinical features of disorders labeled as EKs vary al. 1993; Niemi and Kanerva 1993; Gray et al. 1996).
Therefore, it is clear that the EKs are a heterogeneouswidely among pedigrees, raising the possibility that the
clinical descriptors assigned to these phenotypes serve to group of diseases and that either different mutations in
loricrin or mutations in molecules other than loricringroup them together in a rather loosely deﬁned fashion
(Hopsu-Havu and Peltonen 1970; Nir and Tanzer 1978; will be responsible for variant phenotypes. Nonetheless,
the clinical ﬁndings of palmoplantar keratoderma withMaldonado-Ruiz et al. 1982; Nazzaro and Blanchet-
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Figure 6 Analysis of amino acid sequences of EK mutation. The two upper lines represent the loricrin mutations in the EK family (present
study), 709insC (denoted by boldface on the top line), and in the VS family (Maestrini et al. 1996), 730insG (denoted by boldface on the
second line). Single-letter amino acid translation of the sequence is given directly beneath the nucleotide sequence, and the mutant carboxy-
terminal loricrin sequence resulting from the frameshift and delayed termination codon is underlined. wt Å wild-type sequence; mt Å mutant
sequence (underlined); and * Å termination codon.
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